Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant

NCT00281814

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +63 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Y 90 Ibritumomab Tiuxetan &Rituximab Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma

NCT00073957

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Fletcher Allen Health Care - Medical Center Campus Burlington, Vermont, United States

View Trial Details

Completed

Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT

NCT02294552

Conditions: Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +22 more
Locations: First Pavlov State Medical University of St. Petersburg Saint Petersburg, Russia

View Trial Details

Completed

Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers

NCT00619645

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +49 more
Locations: University of California Davis Cancer Center Sacramento, California, United States

View Trial Details

Completed

Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

NCT00787969

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Illinois CancerCare - Bloomington Bloomington, Illinois, United States

St. Joseph Medical Center Bloomington, Illinois, United States

Graham Hospital Canton, Illinois, United States

View all 144 locations

View Trial Details

Completed

Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)

NCT00667615

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Disease, +7 more
Locations: Memorial Sloan Kettering Cancer Center @ BaskingRidge Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States

Memorial Sloan Kettering Cancer Center New York, United States

Weill Cornell Medical Center New York, United States

View Trial Details

Completed

3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma

NCT02057445

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkins Lymphoma, +10 more
Locations: Children's National Medical Center Washington D.C., District of Columbia, United States

New York Medical College Valhalla, New York, United States

View Trial Details

Completed

A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas

NCT02130869

Conditions: Hemic and Lymphatic Diseases, High-risk Tumor, Immune System Diseases, +14 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation

NCT02252146

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: UCLA Medical Center Los Angeles, California, United States

Emory University Atlanta, Georgia, United States

Cancer Care Specialists of Illinois Decatur, Illinois, United States

Horizon Bio Advance Lafayette, Indiana, United States

View Trial Details

Completed

Rituximab and GM-CSF in Treating Patients With Newly Diagnosed Follicular B-Cell Lymphoma

NCT00411086

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions